Berlin, Germany – South Korea is moving to bolster support for citizens who experienced adverse effects following COVID-19 vaccination, with proposed legislation aiming to strengthen the authority and resources of the national compensation committee. The move comes amid ongoing scrutiny of vaccine safety and a growing demand for more robust support systems for those who believe they suffered harm as a result of the national vaccination program.
On March 17, 2026, Kim Eun-hye, a member of the National Assembly representing the People Power Party, introduced a bill – dubbed the “Corona 19 Substance Vaccine Victim Rights Recovery Act” – that seeks to elevate the COVID-19 Vaccine Damage Compensation Committee to a position under the direct oversight of the Prime Minister. Currently, the committee operates under the Ministry of Health and Welfare. The proposed changes also include a doubling of the committee’s size and the granting of new powers, including the ability to request information and compel the submission of relevant documents. This legislative effort reflects increasing concerns about transparency and accountability in the handling of vaccine-related adverse events.
Expanding the Scope of Vaccine Injury Compensation
The initial “Act on Prevention of Infection and Damage Relief, etc. Of COVID-19” – enacted in 2025 – established a framework for compensating individuals who experienced serious health issues following COVID-19 vaccination. The original law, signed into law by then-Prime Minister Han Duck-soo on April 22, 2025, aimed to provide financial assistance and medical support to those demonstrably harmed by the vaccines. However, critics argue that the existing system has been slow to process claims and lacks sufficient authority to effectively investigate potential issues.
Kim Eun-hye’s proposed amendments address these concerns directly. By placing the compensation committee under the Prime Minister’s office, the bill aims to increase its independence and political weight. The doubling of the committee’s size is intended to expedite the review of claims and ensure a more thorough assessment of individual cases. The addition of information-gathering and document-requesting powers would allow the committee to proactively investigate potential problems and gather evidence more effectively.
Concerns Over Vaccine Quality and Reporting
The push for these legislative changes is fueled, in part, by recent revelations regarding potential quality control issues with some of the COVID-19 vaccines administered in South Korea. According to Kim Eun-hye, a 2026 audit by the Board of Audit and Inspection (BAI) revealed that approximately 1.4 million doses of COVID-19 vaccines containing foreign matter – including mold – were administered to the public even after reports of contamination surfaced. The audit also reportedly found that the Korea Disease Control and Prevention Agency (KDCA) failed to notify the Ministry of Food and Drug Safety (MFDS) of 1,285 reports of foreign matter in vaccines received between March 2021 and October 2024.
These findings have raised serious questions about the oversight of vaccine distribution and the responsiveness of regulatory agencies. The alleged failure to promptly investigate and address reports of contaminated vaccines has fueled public distrust and intensified calls for greater accountability. The audit reportedly revealed that vaccines past their expiration dates were also administered, and that adequate follow-up care was not provided to recipients.
The Scale of South Korea’s Vaccination Campaign
South Korea undertook one of the world’s most rapid and extensive COVID-19 vaccination campaigns. Between 2021 and 2024, approximately 150 million doses of COVID-19 vaccines were administered to the population. The government actively promoted achieving a 70% vaccination rate, particularly in the early stages of the rollout. This aggressive campaign, while credited with helping to control the spread of the virus, has also been linked to the reported adverse events that are now the focus of legislative scrutiny.
Impact on Affected Individuals and Future Policy
The proposed changes to the COVID-19 vaccine compensation law represent a significant step towards addressing the concerns of individuals who believe they have been harmed by the vaccines. The increased authority and resources of the compensation committee could lead to faster claim processing, more thorough investigations, and more equitable compensation for those who have suffered adverse effects. The new information-gathering powers could also help to identify systemic issues in the vaccine supply chain and prevent similar problems from occurring in the future.
However, challenges remain. Establishing a clear causal link between vaccination and specific health problems can be complex and time-consuming. The committee will demand to navigate scientific uncertainties and competing medical opinions to make fair and informed decisions. The success of the new legislation will depend on the willingness of government agencies to cooperate fully with the committee’s investigations and provide access to relevant data.
What In other words for Global Vaccine Safety
The developments in South Korea highlight the importance of robust vaccine safety monitoring systems and transparent compensation mechanisms in all countries. As the world continues to grapple with the long-term effects of the COVID-19 pandemic and prepares for future public health emergencies, ensuring that individuals who experience adverse events following vaccination receive timely and adequate support is crucial for maintaining public trust in immunization programs. The South Korean case serves as a cautionary tale and underscores the need for continuous vigilance and improvement in vaccine safety protocols.
The bill is expected to be debated in the National Assembly in the coming weeks. If passed, it would represent a significant victory for advocates of vaccine injury compensation and could set a precedent for other countries grappling with similar issues. The next key step will be the committee review and potential amendments to the proposed legislation, followed by a full vote by the National Assembly.
World Today Journal will continue to follow this developing story and provide updates as they become available.
Do you have experiences with vaccine side effects or thoughts on vaccine compensation programs? Share your comments below. Please also share this article with your network to raise awareness about this important issue.